StepStone Announces Secondary Offering
September 09, 2024 16:08 ET
|
StepStone Group Inc
NEW YORK, Sept. 09, 2024 (GLOBE NEWSWIRE) -- StepStone Group Inc. (“StepStone”) today announced that it intends to offer for sale in an underwritten offering 4,099,997 shares of StepStone’s Class A...
Calavo Growers, Inc. Announces Third Quarter 2024 Financial Results, Dividend Increase
September 09, 2024 16:06 ET
|
Calavo Growers, Inc.
CVGW Announces Third Quarter 2024 Financial Results, Dividend Increase
UPDATE - IMUNON’s Ovarian Cancer R&D Day to Feature Presentations from IMNN-001 Clinical Study Investigators, Immunology and Biostatistics Experts, and Executive Management
September 09, 2024 16:06 ET
|
Imunon, Inc.
September 18th Event in New York City to Include a Review of the Opportunity for Investigational Therapy IMNN-001 (IL-12) to Treat Advanced Ovarian Cancer and Clinical Development Timeline ...
Hanmi Financial to Participate in the Janney Financial Services Conference
September 09, 2024 16:05 ET
|
Hanmi Bank
LOS ANGELES, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Hanmi Financial Corporation (NASDAQ: HAFC, or “Hanmi”), the parent company of Hanmi Bank (the “Bank”), today announced its participation in the Janney...
Matrix Service Company Reports Fourth Quarter and Full-Year Fiscal 2024 Results; Issues Fiscal 2025 Revenue Guidance
September 09, 2024 16:05 ET
|
Matrix Service Company
TULSA, Okla., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Matrix Service Company (Nasdaq: MTRX), a leading North American industrial engineering, construction, and maintenance contractor, today announced...
Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2024
September 09, 2024 16:05 ET
|
Avid Bioservices, Inc
-- Recorded First Quarter Revenue of $40.2 Million -- -- Signed $66 Million in Net New Business, Resulting in Backlog of $219 Million -- -- Maintained FY2025 Revenue Guidance of Between $160...
Trinity Biotech Provides an Update on the Continued Development of Its Continuous Glucose Monitor Technology
September 09, 2024 16:05 ET
|
Trinity Biotech plc
DUBLIN, Ireland, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions,...
BioCardia Announces Closing of Upsized $7.2 Million Public Offering Priced At-The-Market Under Nasdaq Rules
September 09, 2024 16:05 ET
|
BioCardia, Inc.
SUNNYVALE, Calif., Sept. 09, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary...
IZEA Appoints Digital Leader Patrick Venetucci as Chief Executive Officer
September 09, 2024 16:05 ET
|
IZEA Worldwide, Inc.
ORLANDO, Fla., Sept. 09, 2024 (GLOBE NEWSWIRE) -- IZEA Worldwide, Inc. (NASDAQ: IZEA), a leading provider of influencer marketing technology today announced the appointment of Patrick Venetucci as...
Aprea Therapeutics to Present at the H.C. Wainwright Annual Global Investment Conference
September 09, 2024 16:05 ET
|
Aprea Therapeutics
DOYLESTOWN, Pa., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea” or the “Company”), a clinical stage biopharmaceutical company focused on precision oncology...